<DOC>
	<DOCNO>NCT01649557</DOCNO>
	<brief_summary>This multicenter , 52 week , open label study assess safety tolerability oral OPC-34712 ( 1 6 mg ) monotherapy adult patient schizophrenia . The study conduct outpatient basis . Enrollment study drawn eligible subject complete participation Study 331-07- 203 , investigator 's judgment , would benefit continued treatment oral OPC-34712 .</brief_summary>
	<brief_title>Multicenter , Open-label , Safety Tolerability Study</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>1 . Subjects participate 33107203 , opinion investigator , potential benefit continue administration OPC34712 treatment schizophrenia . 2 . Outpatient status last visit Study 33107203 . 1 . Sexually active male practice two different method birth control study 90 day last dose study medication remain abstinent study 90 day last dose , sexually active female childbearing potential practice two different method birth control study 30 day last dose study medication remain abstinent study 30 day last dose . If employing birth control , two follow precaution must use : vasectomy , tubal ligation , vaginal diaphragm , intrauterine device , birth control pill , birth control depot injection , birth control implant , condom , sponge spermicide . 2 . Females breastfeed and/or positive pregnancy test result prior receive openlabel OPC34712 . 3 . Subjects course participation 33107203 treated violation protocol develop ANY exclusion criterion course participation . 4 . Subjects continue meet applicable inclusion/exclusion criterion Protocol 33107203 last visit ( ie , Week 6 ) Protocol 33107203 . 5 . Subjects represent risk commit suicide base answer `` Yes '' either Question 4 ( Active Suicidal Ideation Some Intent Act , Without Specific Plan ) Question 5 ( Active Suicidal Ideation Specific Plan Intent ) `` Suicidal Ideation '' portion CSSRS , answer `` Yes '' suiciderelated behavior ( actual attempt , interrupt attempt , abort attempt , preparatory act behavior ) `` Suicidal Behavior '' portion CSSRS . A subject suicidal ideation within last 6 month , suicidal behavior within last two year , clinical judgment investigator present serious risk suicide exclude study . 6 . Subjects would likely require prohibited concomitant therapy study . 7 . Any subject , opinion investigator , participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>